Siteman Cancer Center
Center for Advanced Medicine
4921 Parkview Place, Floor LL
St. Louis, MO 63110
(314) 747-7236
Mailing Address:
Washington University School of Medicine
Department of Radiation Oncology
660 South Euclid Avenue, Campus Box 8224
St. Louis, MO 63110
Areas of Clinical Interest:
Head and neck oncology, thoracic cancer, tumors, systemic radiotherapy,
radioimmunotherapy, radioimmunodiagnosis, nuclear oncology, PET
Board Certification:
Radiation Oncology--Certified
Nuclear Medicine--Certified
Medical Education:
Medical Degree: University of Texas Medical School, Houston, Texas, 1991
Residency: Radiation Oncology, Loyola University Medical Center, Chicago,
Illinois, 1995
Residency: Nuclear Medicine, Duke University Medical Center, Durham,
North Carolina, 1997
Fellowship: Radiation Oncology, Mayo Clinic, Rochester, Minnesota, 1998
Hospital Affiliations:
Barnes-Jewish Hospital
Major
or Recent Publications/Awards:
Books
and Book Chapters:
McLendon RE, Enterline DS, Tien RD, Thorstad WL, Bruner JM. Tumors of
Neuroepithelial Origin. In: Bigner DD, McLendon RE and Bruner JM, (eds),
Russell and Rubinstein's Pathology of Tumors of the Nervous System. 6th
edition, New York, New York, Oxford University Press, 1998
Bruner JM, Tien RD, Thorstad WL. Deformations and Other Structural Changes
Produced by Intracranial Tumors. Effects of Radiation and Other Forms of
Therapy on Intracranial and Spinal Tumors and Their Surrounding Tissues.
In: Bigner DD, McLendon RE, Bruner JM, (eds), Russell and Rubinstein's Pathology
of Tumors of the Nervous System. New York, New York, Oxford University Press,
1998
Journal
Articles:
Marriott CJ, Thorstad W, Akabani G, Brown MT, McLendon RE, Hanson MW,
Coleman RE. Locally increased uptake of fluorine-18-fluorodeoxyglucose after
intracavitary administration of iodine-131-labeled antibody for primary
brain tumors. J Nucl Med 1998; 39(8):1376-80
Bigner DD, Brown MT, Friedman AH, Coleman RE, Akabani G, Friedman HS,
Thorstad WL, McLendon RE, Bigner SH, Zhao X-G, Pegram CN, Wikstrand CJ,
Herndon II JE, Vick NA, Paleologos N, Cokgor I, Provenzale JM, Zalutsky
MR. Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of
patients with recurrent malignant gliomas: Phase I trial results. J Clin
Oncol 1998, 16(6):2202-2212
